Adagio Medical Inc. (ADGM)
NASDAQ: ADGM
· Real-Time Price · USD
1.26
-0.03 (-2.33%)
At close: May 01, 2025, 3:59 PM
1.23
-2.38%
After-hours: May 01, 2025, 07:54 PM EDT
Company Description
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias.
It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.
The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories.
Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Adagio Medical Inc.
| Country | United States |
| IPO Date | Jul 23, 2024 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 80 |
| CEO | Todd Usen |
Contact Details
Address: 26051 Merit Circle Laguna Hills, Delaware United States | |
| Website | https://adagiomedical.com |
Stock Details
| Ticker Symbol | ADGM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002006986 |
| CUSIP Number | 00534B100 |
| ISIN Number | US00534B1008 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Todd Usen | Chief Executive Officer & Director |
| Deborah Kaster | Chief Business Officer |
| Dr. Alex Babkin Ph.D. | Chief Technical Officer |
| Ilya Grigorov | Vice President of Global Marketing & Product Management |
| Nabil Jubran | Chief Compliance Officer |
| Olav B. Bergheim | Advisor |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 30, 2025 | 10-K/A | [Amend] Annual Report |
| Apr 28, 2025 | 3 | Filing |
| Apr 23, 2025 | 424B3 | Filing |
| Apr 23, 2025 | 424B3 | Filing |
| Apr 23, 2025 | 8-K | Current Report |
| Apr 02, 2025 | 8-K | Current Report |
| Mar 27, 2025 | S-8 | Filing |
| Mar 27, 2025 | 424B3 | Filing |
| Mar 27, 2025 | 424B3 | Filing |
| Mar 27, 2025 | 10-K | Annual Report |